Imel are cofounders with equity stake in a technology company, Lyssn.io, focused on tools to support training, supervision, and quality assurance of psychotherapy and counseling. Shrikanth S. Narayanan is chief scientist and co-founder with equity stake of Behavioral Signals, a technology company focused on creating technologies for emotional and behavioral machine intelligence. The remaining authors report no conflicts of interest.
With the growing prevalence of psychological interventions, it is vital to have measures which rate the effectiveness of psychological care to assist in training, supervision, and quality assurance of services. Traditionally, quality assessment is addressed by human raters who evaluate recorded sessions along specific dimensions, often codified through constructs relevant to the approach and domain. This is, however, a cost-prohibitive and time-consuming method that leads to poor feasibility and limited use in real-world settings. To facilitate this process, we have developed an automated competency rating tool able to process the raw recorded audio of a session, analyzing who spoke when, what they said, and how the health professional used language to provide therapy. Focusing on a use case of a specific type of psychotherapy called "motivational interviewing", our system gives comprehensive feedback to the therapist, including information about the dynamics of the session (e.g., therapist's vs. client's talking time), low-level psychological language descriptors (e.g., type of questions asked), as well as other high-level behavioral constructs (e.g., the extent to which the therapist understands the clients' perspective). We describe our platform and its performance using a dataset of more than 5000 recordings drawn from its deployment in a real-world clinical setting used to assist training of new therapists. Widespread use of automated psychotherapy rating tools may augment experts' capabilities by providing an avenue for more effective training and skill improvement, eventually leading to more positive clinical outcomes.
Cognitive Behavior Therapy (CBT) is a psychotherapy treatment that uses cognitive change strategies to address mental health problems. Quality assessment of a CBT session is traditionally addressed by human raters who evaluate recorded sessions along specific behavioral codes, a cost prohibitive and time consuming method. In this work we examine how linguistic features can be effectively used to develop an automatic competency rating tool for CBT. We explore both standard, widelyused lexical features and domain-specific ones, adapting methods which have been successfully used in similar psychotherapy session coding tasks. Experiments are conducted on manual transcripts of CBT sessions and on automatically derived ones, thus introducing an end-to-end approach. Our results suggest that a real-world system could be developed to automatically evaluate CBT sessions to assist training, supervision, or quality assurance of services.
In this paper, we present an approach for predicting utterance level behaviors in psychotherapy sessions using both speech and lexical features. We train long short term memory (LSTM) networks with an attention mechanism using words, both manually and automatically transcribed, and prosodic features, at the word level, to predict the annotated behaviors. We demonstrate that prosodic features provide discriminative information relevant to the behavior task and show that they improve prediction when fused with automatically derived lexical features. Additionally, we investigate the weights of the attention mechanism to determine words and prosodic patterns which are of importance to the behavior prediction task.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.